Skip to Content
Merck
CN

Stearic acid, clotting, and thrombosis.

The American journal of clinical nutrition (1994-12-01)
J C Hoak
ABSTRACT

Stearic acid causes hypercoagulability of the blood by activation of factor XII and by aggregation of blood platelets. Injection of unbound stearic acid (sodium salt) into the systemic circulation of dogs was followed by massive generalized thrombosis and sudden death. Similar infusions into birds, which are deficient in factor XII, did not cause hypercoagulability or thrombosis. The effects of the long-chain saturated fatty acids could be prevented by using albumin to bind the stearic acid at a molar ratio of free fatty acid (FFA) to albumin of < 2. The major issue is whether eating foods rich in stearic acid can cause a thrombogenic effect. We have no experimental evidence to support this concept. If a thrombogenic effect of long-chain saturated fatty acids exists in humans, it is most likely to occur as an aberration of fatty acid transport in which the FFA-albumin molar ratio exceeds 2 either as a result of very high plasma FFA concentrations from lipid mobilization or a low concentration of albumin in the blood as found in disease states such as the nephrotic syndrome.

MATERIALS
Product Number
Brand
Product Description

Supelco
Stearic acid, analytical standard
Sigma-Aldrich
Stearic acid, ≥95%, FCC, FG
Sigma-Aldrich
Stearic acid, reagent grade, 95%
Sigma-Aldrich
Stearic acid, Grade I, ≥98.5% (capillary GC)
Supelco
Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Stearic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Stearic acid, European Pharmacopoeia (EP) Reference Standard
USP
Stearic acid, United States Pharmacopeia (USP) Reference Standard